November 26, 2012 08:30 ET Collaboration Represents Significant Progress in Sarepta’s Path to Develop Treatments for Broader DMD Population CAMBRIDGE, MA–(Marketwire – Nov 26, 2012) – Sarepta Therapeutics (NASDAQ: SRPT), […]

 New formulation delivers drug levels that are predicted to significantly increase utrophin production  Summit to progress utrophin upregulator into next stages of development Oxford, UK, 7 November 2012 – Summit […]